GSK Loads up the Potential Milestones from Chemocentryx
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 76 (Table of Contents)
Published: 6 Oct-2006
DOI: 10.3833/pdr.v2006.i76.447 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GlaxoSmithKline and ChemoCentryx entered into license agreement to discover, develop and market drugs for treating various inflammatory diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018